Skip to content
About
Clinical Trials
Resources
Contact
Menu
About
Clinical Trials
Resources
Contact
Chronic Phase (CML-CP)
Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia – Chronic Phase (CML-CP)
Status:
Open
Trial Type:
Chronic Myelogenous Leukemia (Pediatric)
Contact:
Jennifer Welch, MD
jwelch@lifespan.org